PMCPA PRESS RELEASE 15 APRIL - Case ruled in breach of Clause 2

​GSK has breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry.    

Press Release 15 April 2025

GSK – Case/0244/07/24

For producing prescribing information for Omjjara (momelotinib), a black triangle medicinal product subject to additional monitoring which was contraindicated in pregnancy, that was misleading regarding the need for women using hormonal contraceptives to take additional precautions to avoid pregnancy, GSK was ruled in breach of the following clauses of the 2021 Code:

Clause 2           - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 5.1        - Failing to maintain high standards

Clause 6.1        - Producing misleading information

The case report is available at www.pmcpa.org.uk.

Ends

Notes to Editors:
The advertisements will appear in the BMJ and the Nursing Standard in June 2025.

Notes to Editors:

Media Contacts:
For more information contact Alex Fell afell@pmcpa.org.uk 0207 747 8878

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of the ABPI. The Code covers the promotion of medicines for prescribing to health professionals and the provision of information to the public about prescription only medicines.

If you have any concerns about the activities of pharmaceutical companies in this regard, please contact the PMCPA at 2nd Floor, Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB, email: complaints@pmcpa.org.uk, or visit www.pmcpa.org.uk/complaints-procedure/make-a-complaint.

The Code and other information, including details about ongoing cases, can be found on the PMCPA website: www.pmcpa.org.uk.

The PMCPA is a division of the ABPI which is a company limited by guarantee registered in England & Wales no 09826787. Registered office 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.